Mutations that result in loss of ARID1A have been shown to contribute to faster tumorigenesis, progression towards metastasis, and development of chemoresistance across several cancers including ovarian, colon, osteosarcoma, and esophageal cancer [2,3,4,5,6,7,8,9]. The gene discussed is ARID1A; the disease is osteosarcoma.